See also this year's filing and all EDGAR filings for this company.
PDF Report 0001385508_2020_OPIANT_PHARMACEUTICALS_INC.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 5.72907706103121e-05, 'aggregate_val': 5864483, 'exp_sum': 5864819, 'exp_to_value': {'LiabilitiesCurrent': 5609819, 'LiabilitiesNoncurrent': 255000, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001385508, OPIANT PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 39,254,656 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 14,373 |
| 2 | PropertyPlantAndEquipmentNet | 243,039 |
| 3 | remainder_Assets | 768,441 |
| 4 | LiabilitiesCurrent | 5,609,819 |
| 5 | LiabilitiesNoncurrent | 255,000 |
| 6 | remainder_Liabilities | -336 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,197,111 |
| 9 | ResearchAndDevelopmentExpense | 9,079,351 |
| 10 | remainder_Expenses | 8,154,616 |
| 11 | remainder_Revenues | 40,519,800 |
| 12 | remainder_NetIncome | 504,328 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 40,280,509 |
| 1 | Liabilities | 5,864,483 |
| 2 | Expenses | 29,431,078 |
| 3 | Revenues | 40,519,800 |
| 4 | StockholdersEquity | 34,416,026 |
| 5 | NetIncome | 11,593,050 |
| 6 | ComprehensiveNetIncome | 11,593,050 |
| 7 | BaseVar | 58,300,099 |
| 8 | EconomicCapitalRatio | 3.07 |
Edgar->Model Mapping
Feature Distribution
Change over Time
